Functional variants of the pentraxin 3 gene are associated with the metastasis and progression of prostate cancer
- PMID: 39187920
- PMCID: PMC11347125
- DOI: 10.1111/jcmm.70041
Functional variants of the pentraxin 3 gene are associated with the metastasis and progression of prostate cancer
Abstract
Age, ethnic background and genetic components have been identified as the established risks for prostate cancer (PCa). Pentraxin 3 (PTX3), originally identified as a pattern-recognition molecule for defence against infectious agents, has multiple functions in tissue repair and in the regulation of cancer-associated inflammation. In this study, we sought to investigate the impact of PTX3 gene variants on the development of PCa. Genotypes of four common single-nucleotide polymorphisms (SNPs) of PTX3 gene, including rs1840680, rs2305619, rs3816527 and rs2120243, were profiled among 705 PCa patients and 705 ethnicity-matched controls. In this study, we found that patients who carry at least one minor allele (C) of rs3816527 (AC and CC) tended to develop advanced forms of diseases (clinical large T stage, OR, 1.593, p = 0.032; pathologically-confirmed nodal spread, OR, 1.987, p = 0.011; metastatic tumour, OR, 3.896, p = 0.032) as compared with those homologous for the major allele (AA). Further stratification analysis showed that such association of rs3816527 with lymphatic and distal metastasis of PCa was accentuated in the younger age group (≤65 at diagnosis) but not seen in the older age group (>65 at diagnosis), suggesting an age-specific effect of PTX3 variants. Prediction of PTX3 protein structure implied that polymorphism may alter the quaternary organization and oligomerization of PTX3 protein. Moreover, our gene silencing experiments and survey of public datasets revealed that elevation of PTX3 levels in PCa was required for cell migration and associated with tumour metastasis. Our results highlight an association of PTX3 rs3816527 with the progression of PCa.
Keywords: metastasis; pentraxin 3; prostate cancer; single‐nucleotide polymorphism.
© 2024 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest related to this study.
Figures
Similar articles
-
Pentraxin 3 Gene Polymorphisms and Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Patients.Clin Infect Dis. 2018 Jan 6;66(2):261-267. doi: 10.1093/cid/cix749. Clin Infect Dis. 2018. PMID: 29020397
-
Pentraxin 3 Genetic Variants and The Risk of Active Pulmonary Tuberculosis.Egypt J Immunol. 2017 Jan;24(1):21-27. Egypt J Immunol. 2017. PMID: 29120574
-
Association of the long pentraxin PTX3 gene polymorphism (rs3816527) with migraine in an Iranian population.J Neurol Sci. 2015 Feb 15;349(1-2):185-9. doi: 10.1016/j.jns.2015.01.015. Epub 2015 Jan 16. J Neurol Sci. 2015. PMID: 25604633
-
The yin-yang of long pentraxin PTX3 in inflammation and immunity.Immunol Lett. 2014 Sep;161(1):38-43. doi: 10.1016/j.imlet.2014.04.012. Epub 2014 May 1. Immunol Lett. 2014. PMID: 24792672 Free PMC article. Review.
-
The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis.Front Immunol. 2019 Apr 12;10:794. doi: 10.3389/fimmu.2019.00794. eCollection 2019. Front Immunol. 2019. PMID: 31031772 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous